ABT
Abbott Laboratories
Stock
$96.69−2.14 (−2.17%)Close Oct 1, 2026
| Net income (TTM) | YoY | 5-year CAGR | 10-year CAGR |
|---|---|---|---|
| $5.4B | −61.2% | 7.7% | 4.0% |
| Net income (TTM) | $5.4B |
|---|---|
| YoY | −61.2% |
| 5-year CAGR | 7.7% |
| 10-year CAGR | 4.0% |
Net income
| Period | Net income | YoY |
|---|---|---|
| 2025 | $6.5B | −51.3% |
| 2024 | $13.4B | +134.2% |
| 2023 | $5.7B | −17.5% |
| 2022 | $6.9B | −2.0% |
| 2021 | $7.1B | +57.3% |
| 2020 | $4.5B | +21.9% |
| 2019 | $3.7B | +55.7% |
| 2018 | $2.4B | +396.4% |
| 2017 | $477M | −65.9% |
| 2016 | $1.4B | −68.3% |
| 2015 | $4.4B | +93.7% |
| 2014 | $2.3B | −11.3% |
| 2013 | $2.6B | −56.8% |
| 2012 | $6.0B | +26.1% |
| 2011 | $4.7B | +2.2% |
| 2010 | $4.6B | −19.5% |
| 2009 | $5.7B | +17.7% |
| 2008 | $4.9B | +35.3% |
| 2007 | $3.6B | — |